DID YOU KNOW?
- Biotechnology, pharmaceutical, and medical device companies are prime candidates for valuable federal and state R&D tax credits.
- Many of the drug & product development and process improvement activities performed by biotechnology companies may qualify for sizable federal and state R&D tax credits.
- The R&D tax credit is based on “qualified research expenses” (QREs) – for every dollar spent on QREs, you can earn up to 8.0% in federal tax credits! Additionally, over 40 states offer similar R&D tax incentives that can double benefits in some cases.
BIOTECHNOLOGY MANUFACTURING CASE STUDY
ITEM |
AVERAGE ANNUAL AMOUNT |
Gross Revenues |
$ 25,000,000 |
Total Payroll |
$ 3,600,000 |
Qualified Research Expenses (QREs) |
$ 2,500,000 |
Net Federal Credits |
$ 152,000 |
Net State Credits |
$ 136,000 |
TOTAL NET FEDERAL AND STATE CREDITS |
$ 288,000 |
BIOTECHNOLOGY MANUFACTURING QUALIFYING ACTIVITIES
◾ Product Design & Testing
◾ First-Article Runs
◾ Clinical Trials
◾ CNC Programming
◾ Tooling Development
◾ Equipment Development
◾ Process Design & Development
◾ Quality Assurance
DRUG DEVELOPMENT QUALIFYING ACTIVITIES
◾ Identification of Receptor Targets
◾ Computer Modeling
◾ Assay Development
◾ Pharmacology
◾ Clinical Testing
◾ Process Design & Validation
◾ Equipment Selection